Abstract
The most common pathology in sports is muscle injury. There are several reasons to establish a new Protocol for the treatment of muscle injuries: there is no such thing as a single criterion that says how and when treatments or certain patterns of treatment need to be applied; there are several classifications of nonhomogeneous muscle injuries [13] with a great variety of interobserver; patterns of treatment have been based on individual medical experience rather than scientific homogeneous reproducible criteria. As a consequence, functional results have proven diverse, unpredictable, and unforeseeable. Goal is to elaborate a Protocol to reconcile and combine the therapeutical process by applying actual knowledge on biophysiology which will eventually set up a plan of treatment based on temporary biological criteria of muscle repair.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alonso, J.M., Guillén, P.: Tratamiento conservador de las lesiones músculo tendinosas. Medicine 7, 6579–6583 (1999)
Ambrosio, F., Kadi, F., Lexell, J., Fitzgerald, G.K., Boninger, M.L., Huard, J.: The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscle pathology. Am. J. Phys. Med. Rehabil. 88, 145–155 (2009)
Aoi, W., Naito, Y., Nakamura, T., Akagiri, S., Masuyama, A., Takano, T., Mizushima, K., Yoshikawa, T.: Inhibitory effect of fermented milk on delayed-onset muscle damage after exercise. J. Nutr. Biochem. 18, 140–145 (2007)
Bedair, H.S., Karthikeyan, T., Quintero, A., Li, Y., Huard, J.: Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am. J. Sports Med. 36, 1929–1936 (2008)
Bedair, H., Liu, T.T., Kaar, J.L., Badlani, S., Russell, A.J., Li, Y., Huard, J.: Matrix metalloproteinase-1 therapy improves muscle healing. J. Appl. Physiol. 102, 2338–2345 (2007)
Brack, A.S., Conboy, M.J., Roy, S., Lee, M., Kuo, C.J., Keller, C., Rando, T.A.: Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317, 807–810 (2007)
Brzóska, E., Grabowska, I., Hoser, G., Stremi?ska, W., Wasilewska, D., Machaj, E.K., Pojda, Z., Moraczewski, J., Kawiak, J.: Participation of stem cells from human cord blood in skeletal muscle regeneration of SCID mice. Exp. Hematol. 34, 1262–1270 (2006)
Chan, Y.S., Li, Y., Foster, W., Fu, F.H., Huard, J.: The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am. J. Sports Med. 33, 43–51 (2005)
Concejero, V., Guillén, P., Fernández-Jaén, T.F.: Clínica y tratamiento de las lesiones musculotendinosas en el deporte. Medicine 7, 6568–6573 (1999)
Creaney, L., Hamilton, B.: Growth factor delivery methods in the management of sports injuries: the state of play. Br. J. Sports Med. 42, 314–320 (2008)
De Coppi, P., Bellini, S., Conconi, M.T., Sabatti, M., Simonato, E., Gamba, P.G., Nussdorfer, G.G., Parnigotto, P.P.: Myoblast-acellular skeletal muscle matrix constructs guarantee a long-term repair of experimental full-thickness abdominal wall defects. Tissue Eng. 12, 1929–1936 (2006)
Doukas, J., Blease, K., Craig, D., Ma, C., Chandler, L.A., Sosnowski, B.A., Pierce, G.F.: Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol. Ther. 5, 517–527 (2002)
Fernández Jaén, T.F.: Protocolo de actuación ante una lesión aguda músculo tendinosa en el deporte. Revista de traumatología del Deporte. 1, Púb. Internet (2008) http://rtd.ucam.edu/
Floss, T., Arnold, H.H., Braun, T.: A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11, 2040–2051 (1997)
Garrido, J.J., Guillén, P.: Etiología de las lesiones músculo tendinosas. Medicine 7, 6565–6567 (1999)
Greig, M., Siegler, J.C.: Soccer-specific fatigue and eccentric hamstrings muscle strength. J. Athl. Train. 44, 180–184 (2009)
Guillen, P., Fernández Jaén, T.F., Fernández Jiménez, M.A., Guillén, I.: Diagnóstico de las lesiones musculares. Traumatol. Deporte 1, 31–34 (2003)
Guillen, P., Fernández Jaén, T.F., Guillén, I., Fernández Jimenez, M.A.: Clínica de las lesiones musculares. Traumatol. Deporte 1, 35–38 (2003)
Guillen, P., Garrido, J.J., Fernández Jaén, T.F.: Etiopatogenia de las lesiones musclees. Traumatol. Deporte 0, 37–39 (2002)
Hammond, J.W., Hinton, R.Y., Curl, L.A., Muriel, J.M., Lovering, R.M.: Use of autologous platelet-rich plasma to treat muscle strain injuries. Am. J. Sports Med. 37(6), 1135–1142 (2009)
Herrador, M.A.: Lesiones musculares del futbolista. Lesiones del fútbol. Patología e historia. IMXC, 19–21 (1996)
Huard, J., Li, Y., Fu, F.: Muscle injuries and repair: current trends in research. J. Bone Joint Surg. Am. 84, 822–832 (2002)
Ishida, W., Mori, Y., Lakos, G., Sun, L., Shan, F., Bowes, S., Josiah, S., Lee, W.C., Singh, J., Ling, L.E., Varga, J.: Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo. J. Invest. Dermatol. 126, 1733–1744 (2006)
Jaroszewski, J., Bakowski, P., Tabiszewski, M.: Latest standards of muscle injury prophylactic activities, treatment and rehabilitation. Chir. Narzadów Ruchu Ortop. Pol. 73, 377–380 (2008)
Järvinen, T., Järvinen, T., Käätiänien, M., Kalimo, H., Järvinen, M.A.: Muscle injuries: biology and treatment. Am. J. Sports Med. 33, 745–764 (2005)
Jiménez-Diaz, F.: Muscle injuries in sport. Int. J. Sport Sci. 2, 55–67 (2006)
Kanangat, S., Postlethwaite, A.E., Higgins, G.C., Hasty, K.A.: Novel functions of intracellular IL-1ra in human dermal fibroblasts: implications in the pathogenesis of fibrosis. J. Invest. Dermatol. 126, 756–765 (2006)
Lai, X.N., Wang, Z.G., Zhu, J.M., Wang, L.L.: Effect of substance P on gene expression of transforming growth factor beta-1 and its receptors in rat’s fibroblasts. Chin. J. Traumatol. 6, 350–354 (2003)
Langsdorf, A., Do, A.T., Kusche-Gullberg, M., Emerson Jr., C.P., Ai, X.: Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev. Biol. 311, 464–477 (2007)
LeClair, R.J., Durmus, T., Wang, Q., Pyagay, P., Terzic, A., Lindner, V.: Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ. Res. 100, 826–833 (2007)
Li, Y., Wen, X., Spataro, B.C., Hu, K., Dai, C., Liu, Y.: Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J. Am. Soc. Nephrol. 17, 54–65 (2006)
Maeda, K., Kanda, F., Okuda, S., Ishihara, H., Chihara, K.: Transforming growth factor-beta enhances connective tissue growth factor expression in L6 rat skeletal myotubes. Neuromuscul. Disord. 27, 234–240 (2005)
Magee, T.R., Artaza, J.N., Ferrini, M.G., Vernet, D., Zuniga, F.I., Cantini, L., Reisz-Porszasz, S., Rajfer, J., Gonzalez-Cadavid, N.F.: Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J. Gene Med. 8, 1171–1178 (2006)
Mourkioti, F., Kratsios, P., Luedde, T., Song, Y.H., Delafontaine, P., Adami, R., Parente, V., Bottinelli, R., Pasparakis, M., Rosenthal, N.: Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and induces regeneration. J. Clin. Invest. 116, 2866–2868 (2006)
Negishi, S., Li, Y., Usas, A., Fh, Fu, Huard, J.: The effect of relaxin treatment on skeletal muscle injuries. Am. J. Sports Med. 33, 1816–1824 (2005)
Ochoa, O., Sun, D., Reyes-Reyna, S.M., Waite, L.L., Michalek, J.E., McManus, L.M., Shireman, P.K.: Delayed angiogenesis and VEGF production in CCR2-/- mice during impaired skeletal muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, 651–661 (2007)
Okunieff, P., Xu, J., Hu, D., Liu, W., Zhang, L., Morrow, G., Pentland, A., Ryan, J.L., Ding, I.: Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int. J. Radiat. Oncol. Biol. Phys. 65, 890–898 (2006)
Orchard, J.: Management of muscle and tendón injuries in footballers. Aust. Fam. Physician 32, 489–493 (2003)
Payne, T.R., Oshima, H., Okada, M., Momoi, N., Tobita, K., Keller, B.B., Peng, H., Huard, J.: A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J. Am. Coll. Cardiol. 50, 1685–1687 (2007)
Quinn, L.S., Anderson, B.G., Plymate, S.R.: Muscle-specific overexpression of the type-1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3-K, and not calcineurin, signaling. Am. J. Physiol. Endocrinol. Metab. 293, 1538–1551 (2007)
Quintero, A.J., Wright, V.J., Fu, F.H., Huard, J.: Stem cells for the treatment of skeletal muscle injury. Clin. Sports Med. 28, 1–11 (2009)
Rönty, M.J., Leivonen, S.K., Hinz, B., Rachlin, A., Otey, C.A., Kähäri, V.M., Carpén, O.M.: Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J. Invest. Dermatol. 126, 2387–2396 (2006)
Schertzer, J.D., Lynch, G.S.: Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther. 13, 1657–1664 (2006)
Shen, W., Li, Y., Tang, Y., Cummins, J., Huard, J.: NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am. J. Pathol. 167, 1105–1117 (2005)
Shi, M., Ishikawa, M., Kamei, N., Nakasa, T., Adachi, N., Deie, M., Asahara, T., Ochi, M.: Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells 27, 949–960 (2009)
Shi, Y.F., Zhang, Q., Cheung, P.Y., Shi, L., Fong, C.C., Zhang, Y., Tzang, C.H., Chan, B.P., Fong, W.F., Chun, J., Kung, H.F., Yang, M.: Effects of rhDecorin on TGF-beta1 induced human hepatic stellate cells LX-2 activation. Biochim. Biophys. Acta 1760, 1587–1595 (2006)
Shibata, M., Matsumoto, K., Aikawa, K., Muramoto, T., Fujimura, S., Kadowaki, M.: Gene expression of myostatin during development and regeneration of skeletal muscle in Japanese Black Cattle. J. Anim. Sci. 84, 2983–2989 (2006)
Siriett, V., Salerno, M.S., Berry, C., Nicholas, G., Bower, R., Kambadur, R., Sharma, M.: Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol. Ther. 15, 1407–1409 (2007)
Smith, C.A., Stauber, F., Waters, C., Alway, S.E., Stauber, W.T.: Transforming growth factor-beta following skeletal muscle strain injury in rats. J. Appl. Physiol. 102, 755–761 (2007)
Strasser, E.M., Wessner, B., Roth, E.: Cellular regulation of anabolism and catabolism in skeletal muscle during immobilisation, aging and critical illness. Wien. Klin. Wochenschr. 119, 337–348 (2007)
Summan, M., Warren, G.L., Mercer, R.R., Chapman, R., Hulderman, T., Van Rooijen, N., Simeonova, P.P.: Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, 1488–1495 (2006)
Suzuki, K., Peake, J., Nosaka, K., Okutsu, M., Abbiss, C.R., Surriano, R., Bishop, D., Quod, M.J., Lee, H., Martin, D.T., Laursen, P.B.: Changes in markers of muscle damage, inflammation and HSP70 after an ironman triathlon race. Eur. J. Appl. Physiol. 98, 525–534 (2006)
Torrente, Y., El Fahime, E., Caron, N.J., Del Bo, R., Belicchi, M., Pisati, F., Tremblay, J.P., Bresolin, N.: Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant. 12, 91–100 (2003)
Toumi, H., F’guyer, S., Best, T.M.: The role of neutrophils in injury and repair following muscle stretch. J. Anat. 208, 459–470 (2006)
Uutela, M., Wirzenius, M., Paavonen, K., et al.: PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104, 3198–204 (2004)
Vega, A.: Tratamiento con electroterapia y masoterapia simultanea. Lesiones deportiva Ed. Mapfre Med. 269–274 (1996)
Viita, H., Markkanen, J., Eriksson, E., Nurminen, M., Kinnunen, K., Babu, M., Heikura, T., Turpeinen, S., Laidinen, S., Takalo, T., Ylä-Herttuala, S.: 15-Lipoxygenase-1 prevents vascular endothelial growth factor A and placental growth factor induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ. Res. 102, 177–184 (2008)
Wagner, K.R., Liu, X., Chang, X., Allen, R.E.: Muscle regeneration in the prolonged absence of myostatin. Proc. Natl Acad. Sci. USA 102, 2519–2524 (2005)
Wehling, P., Moser, C., Frisbie, D., McIlwraith, C.W., Kawcak, C.E., Krauspe, R., Reinecke, J.A.: Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs 21, 323–332 (2007)
Welle, S., Bhatt, K., Pinkert, C.A., Tawil, R., Thornton, C.A.: Muscle growth after postdevelopmental myostatin gene knockout. Am. J. Physiol. Endocrinol. Metab. 292, E985–E991 (2007)
Willecke, K., Sáez, J.C.: Injury of skeletal muscle and specific cytokines induce the expression of gap junction channels in mouse dendritic cells. J. Cell. Physiol. 211, 649–660 (2007)
Zhu, J., Li, Y., Shen, W., Qiao, C., Ambrosio, F., Lavasani, M., Nozaki, M., Branca, M.F., Huard, J.: Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J. Biol. Chem. 282, 25852–25863 (2007)
Acknowledgments
Carlos Revilla, MD. Clínica CEMTRO, Madrid, Spain.
Prof. Pedro Cuevas. Hospital Ramon y Cajal, Madrid, Spain.
Antonio Manquillo, MD. Clínica CEMTRO, Madrid, Spain.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jaén, T.F.F., García, P.G. (2012). New Protocol for Muscle Injury Treatment. In: Doral, M. (eds) Sports Injuries. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15630-4_114
Download citation
DOI: https://doi.org/10.1007/978-3-642-15630-4_114
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-15629-8
Online ISBN: 978-3-642-15630-4
eBook Packages: MedicineMedicine (R0)